SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms

被引：15
|
作者：
Fabiani, Emiliano [1 ]
Falconi, Giulia [1 ]
Fianchi, Luana [1 ]
Criscuolo, Marianna [1 ]
Leone, Giuseppe [1 ]
Voso, Maria Teresa [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Hematol, Rome, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷 / 09期
关键词：
SETBP1; mutations; therapy-related myeloid neoplasms; MYELODYSPLASTIC SYNDROMES; DISEASE PROGRESSION; LEUKEMIA; RECURRENT;
D O I：
10.3324/haematol.2014.108159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E152 / E153
页数：2
相关论文
共 50 条
  • [41] Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
    Sperling, Adam S.
    Guerra, Veronica A.
    Kennedy, James A.
    Yan, Yuanqing
    Hsu, Joanne, I
    Wang, Feng
    Nguyen, Andrew T.
    Miller, Peter G.
    McConkey, Marie E.
    Barrios, Vanessa A. Quevedo
    Furudate, Ken
    Zhang, Linda
    Kanagal-Shamanna, Rashmi
    Zhang, Jianhua
    Little, Latasha
    Gumbs, Curtis
    Daver, Naval
    DiNardo, Courtney D.
    Kadia, Tapan
    Ravandi, Farhad
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Futreal, P. Andrew
    Ebert, Benjamin L.
    Takahashi, Koichi
    BLOOD, 2022, 140 (16) : 1753 - 1763
  • [42] Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution
    Fabiani, Emiliano
    Cristiano, A.
    Hajrullaj, H.
    Falconi, G.
    Leone, G.
    Voso, M. T.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [43] The role of clonal progression leading to the development of therapy-related myeloid neoplasms
    Guarnera, Luca
    Pascale, Maria Rosaria
    Hajrullaj, Hajro
    Cristiano, Antonio
    Mallegni, Flavia
    Onorato, Angelo
    Voso, Maria Teresa
    Fabiani, Emiliano
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3507 - 3517
  • [44] Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms
    Richard, Melissa A.
    Yan, Chengcheng
    Chen, Yanjun
    Gibson, Christopher J.
    Kalra, Rashi
    Bosworth, Alysia
    Crossman, David K.
    Singh, Purnima
    Hageman, Lindsey
    He, Jianbo
    Armenian, Saro H.
    Vose, Julie
    Weisdorf, Daniel J.
    Ebert, Benjamin L.
    Yasui, Yutaka
    Cheng, Changde
    Forman, Stephen J.
    Bhatia, Smita
    Bhatia, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (31)
  • [45] Therapy-related myeloid neoplasms with different latencies: a detailed clinicopathologic analysis
    Liu, Yen-Chun
    Illar, Gwendolyn M.
    Al Amri, Raniah
    Canady, Briana C.
    Rea, Bryan
    Yatsenko, Svetlana A.
    Geyer, Julia T.
    MODERN PATHOLOGY, 2022, 35 (05) : 625 - 631
  • [46] What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms
    Voso, Maria Teresa
    Falconi, Giulia
    Fabiani, Emiliano
    BLOOD, 2021, 138 (09) : 749 - 757
  • [47] The impact of SETBP1 mutations in neurological diseases and cancer
    Kohyanagi, Naoki
    Ohama, Takashi
    GENES TO CELLS, 2023, 28 (09) : 629 - 641
  • [48] Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature
    Wang, L.
    Du, F.
    Zhang, H. -M.
    Wang, H. -X.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (07) : 583 - 587
  • [49] Therapy-Related Myeloid Neoplasms in Patients with Neuroendocrine Neoplasms after Peptide Receptor Radionuclide Therapy: A Systematic Review
    Sonbol, M.
    Hilal, T.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2020, 110 : 105 - 105
  • [50] Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT
    Berger, Gerbrig
    Kroeze, Leonie I.
    Koorenhof-Scheele, Theresia N.
    de Graaf, Aniek O.
    Yoshida, Kenichi
    Ueno, Hiroo
    Shiraishi, Yuichi
    Miyano, Satoru
    van den Berg, Eva
    Schepers, Hein
    van der Reijden, Bert A.
    Ogawa, Seishi
    Vellenga, Edo
    Jansen, Joop H.
    BLOOD, 2018, 131 (16) : 1846 - 1857
12345